Injectable codeine is available for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may result in nonimmune mast-mobile degranulation and resulting anaphylactoid response. Codeine suppositories can also be marketed in certain nations. In Ireland, new restrictions arrived into impact on 1 August 2010[90] relating to codeine, because https://www.codeingil.com/